U-Chart Analysis:TAIKO PHARMACEUTICAL CO.,LTD.:4574

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TAIKO PHARMACEUTICAL CO.,LTD. Go to web site 4574 Medicals 東証プライム December 1, 2000 2009.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020
Cash and Cash Equivalents 5,484 3,105 5,796 4,945 9,906
Other Current AssetsHelp 3,625 4,451 7,987 14,877 6,678
Tangible Fixed AssetsHelp 3,581 6,397 7,113 9,447 7,108
Intangible Fixed AssetHelp 1 222 299 319 220
Investments and OthersHelp 529 871 1,340 2,170 1,561
Total AssetsHelp 13,220 15,046 22,535 31,758 25,474
Total Current LiabilitiesHelp 4,460 4,261 5,914 8,913 6,048
Total Long-term LiabilitiesHelp 2,021 2,741 3,814 64 52
Shareholder's EquityHelp 6,739 8,044 12,807 22,781 19,374
Total LiabilitiesHelp 13,220 15,046 22,535 31,758 25,474

TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020
Amount of Sales 6,120 5,040 11,299 17,583 14,966
Total Sales 6,120 5,040 11,299 17,583 14,966
Cost of SalesHelp 3,543 3,961 7,973 5,263 4,358
Other Costs and RevenueHelp 6,187 5,973 12,919 8,468 8,155
Total CostsHelp 9,730 9,934 20,892 13,731 12,513
Net RevenueHelp 2,577 1,079 3,326 12,320 10,608
Earnings Before TaxHelp -3,563 -4,869 -8,887 5,374 3,504
Net IncomeHelp -3,610 -4,894 -9,593 3,852 2,453
Net Income -3,610 -4,894 -9,593 3,852 2,453

TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020
Operating Cash Flow(OFC)Help -307 -1,993 -1,596 -1,517 3,493
Investing Cash Flow(ICF)Help 1,166 190 -1,622 -2,760 -448
Financing Cash FlowHelp 1,539 -997 3,959 -649 -581
Exchange Difference of Cash and Cash EquivalentsHelp 49 76 82 -22 -10
Net Increase and Decrease in Cash and Cash Equivalentsn 2,447 -2,724 823 -4,948 2,453

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TAIKO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Shionogi & Co.,Ltd.
UMN Pharma Inc.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
MIZUHO MEDY CO.,LTD.
Tsubota Laboratory Incorporated
NIPPON CHEMIPHAR CO.,LTD.
Kringle Pharma,Inc.
EIKEN CHEMICAL CO.,LTD.
DAIICHI SANKYO COMPANY, LIMITED
Nissui Pharmaceutical Co.,Ltd.